IL6 and colitis: On evaluation in vivo, the lead compounds showed significant activity in several models of murine colitis, for example, PH46 (2) reduced colon cytokine levels of TNFα, IL-6 and IL1b in DSS colitis mice.[4] These molecules also prevented histological damage to colons.